(MENAFN) Early on Wednesday, Apr. 14 Tokyo shares lost ground as shareholder sentiment was diminished by a more robust yen versus the USD and worries over Johnson & Johnson's COVID-19 vaccine after it was stopped by U.S. health authorities because of cases of blood-clotting.
The 225-issue Nikkei Stock Average dropped 101.76 points, or 0.34 percent, from Tuesday, reaching 29,649.85.
In the meantime, the broader Topix indicator of all First Section issues on the Tokyo Stock Exchange declined 5.96 points, or 0.30 percent, hitting 1,952.59.
Among those that dropped the most by the morning break were textile and apparel, nonferrous metal and pulp and paper issues.
MENAFN14042021000045011361ID1101912791
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.